The shifting patterns of HIV encephalitis neuropathology

Neurotoxicity Research

Volumn 8, Issue 1-2, 2005, Pages 51-61

  Everall, Ian P ^a   Hansen, Lawrence A ^a,b   Masliah, Eliezer ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyloid; Chronic; Encephalitis; HAART; HCV; HIV; Methamphetamine; Opportunistic infections; White matter

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; HUMAN; NERVE CELL; NERVOUS SYSTEM; PATHOLOGY; PSYCHOLOGICAL ASPECT; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS DEMENTIA COMPLEX; ANIMALS; HUMANS; NERVOUS SYSTEM; NEURONS;

EID: 33644839923     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033819     Document Type: Article

References (125)

1. Achim C, R Schrier and C Wiley (1992) Immunopathogenesis of HIV encephalitis. Brain Pathol. 1, 177-184.
2. Achim CL, MP Heyes and C Wiley (1993) Quantitation of human immunodeficiency virus, immune activation factors, and quino-linic acid in AIDS brains. J. Clin. Invest. 91, 2769-2775.
3. Adle-Biassette H, Y Levy, M Colombel, F Poron, S Natchev, C Keohane and F Gray (1995) Neuronal apoptosis in HIV infection in adults. Neuropathol. Appl. Neurobiol. 21, 218-227.
4. Ammassari A, G Scoppettuolo, R Murri, P Pezzotti, A Cingolani, C Del Borgo, A De Luca, A Antinori and L Ortona (1998) Changing disease patterns in focal brain lesion-causing disorders in AIDS. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18, 365-371.
5. Ammassari A, A Cingolani, P Pezzotti, DA De Luca, R Murri, ML Giancola, LM Larocca and A Antinori (2000) AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology 55, 1194-1200.
6. Anderson CE, GS Tomlinson, B Pauly, FW Brannan, A Chiswick, R Brack-Werner, P Simmonds and JE Bell (2003) Relationship of Nef-positive and GFAP-reactive astrocytes to drug use in early and late HIV infection. Neuropathol. Appl. Neurobiol. 29, 378-388.
7. Anthony IC, SN Ramage, FW Carnie, P Simmonds and JE Bell (2005) Influence of HAART on HIV-related CNS disease and neuroinflammation. J. Neuropathol. Exp. Neurol. 64, 529-536.
8. Antinori A, A Ammassari, R Luzzati, A Castagna, R Maserati, G Rizzardini, A Ridolfo, M Fasan, E Vaccher, G Landonio, M Scerrati, A Rocca, G Butti, A Nicolato, A Lazzarin and U Tirelli (2000) Role of brain biopsy in the management of focal brain lesions in HIV-infected patients. Gruppo Italiano Cooperativo AIDS & Tumori. Neurology 54, 993-997.
9. Arese M, C Ferrandi, L Primo, G Camussi and F Bussolino (2001) HIV-1 Tat protein stimulates in vivo vascular permeability and lymphomononuclear cell recruitment. J. Immunol. 166, 1380-1388.
10. Asare E, G Dunn, J Glass, J McArthur, P Luthert, P Lantos and I Everall (1996) Neuronal pattern correlates with the severity of human immunodeficiency virus-associated dementia complex. Usefulness of spatial pattern analysis in clinicopathological studies. Am. J. Pathol. 148, 31-38.
11. Aylward EH, PD Brettschneider, JC McArthur, GJ Harris, TE Schlaepfer, JD Henderer, PE Barta, AY Tien and GD Pearlson (1995) Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am. J. Psychiatry 152, 987-994.
12. Bagasra O, E Lavi, L Bobroski, K Khalili, JP Pestaner, R Tawadros and RJ Pomerantz (1996) Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ polymerase chain reaction and immu-nohistochemistry. Aids 10, 573-585.
13. Bell JE (2004) An update on the neuropathology of HIV in the HAART era. Histopathology 45, 549-559.
14. Bell JE, RP Brettle, A Chiswick and P Simmonds (1998) HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 121 (Pt 11), 2043-2052.
15. Benveniste EN (1994) Cytokine circuits in brain. Implications for AIDS dementia complex. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 72, 71-88.
16. Brandimarti R, MZ Khan, AFatatis and O Meucci (2004) Regulation of cell cycle proteins by chemokine receptors: A novel pathway in human immunodeficiency virus neuropathogenesis? J. Neurovirol. 10(Suppl. 1), 108-112.
17. Brew B, M Rosenblum, K Cronin and R Price (1995) AIDS dementia comples and HIV-1 brain infection: Clinical-virological correlations. Ann. Neurol. 38, 563-570.
18. Budka H (1991) Neuropathology of human immunodeficiency virus infection. Brain Pathol. 1, 163-175.
19. Budka H, G Costanzi, S Cristina, A Lechi, C Parravicini, R Trabattoni and L Vago (1987) Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol. (Berl.) 75, 185-198.
20. Buttini M, CE Westland, E Masliah, AM Yafeh, T Wyss-Coray and L Mucke (1998) Novel role of human CD4 molecule identified in neurodegeneration. Nature Med. 4, 441-446.
21. Cherner M, E Masliah, RJ Ellis, TD Marcotte, DJ Moore, I Grant and RK Heaton (2002) Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology 59, 1563-1567.
22. Chung RT, AY Kim and B Polsky (2001) HIV/Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy. Antivir. Chem. Chemother. 12(Suppl. 1), 73-91.
23. Cook JE, S Dasgupta, LD Middaugh, EC Terry, PR Gorry, SL Wesselingh and WR Tyor (2005) Highly active antiretroviral therapy and human immunodeficiency virus encephalitis. Ann. Neurol. 57, 795-803.
24. Cosenza MA, ML Zhao, Q Si and SC Lee (2002) Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol. 12, 442-455.
25. Cysique LA, P Maruff and BJ Brew (2004) Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/ acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: A combined study of two cohorts. J. Neurovirol. 10, 350-357.
26. Dallasta L, L Pisarov, J Esplen, J Werley, A Moses, J Nelson and C Achim (1999) Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155, 1915-1927.
27. Diesing TS, S Swindells, H Gelbard and HE Gendelman (2002) HIV-1-associated dementia: A basic science and clinical perspective. AIDS Read 12, 358-368.
28. Dougherty RH, RL Skolasky Jr and JC McArthur (2002) Progression of HIV-associated dementia treated with HAART. AIDS Read 12, 69-74.
29. Ellis RJ, K Hsia, SA Spector, JA Nelson, RK Heaton, MR Wallace, I Abramson, JH Atkinson, I Grant and JA McCutchan (1997) Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann. Neurol. 42, 679-688.
30. Everall I, P Luthert and P Lantos (1991) Neuronal loss in the frontal cortex in HIV infection. Lancet 337, 1119-1121.
31. Everall I, F Gray, H Barnes, M Durigon, P Luthert and P Lantos (1992) Neuronal loss in symptom-free HIV infection. Lancet 340, 1413.
32. Everall I, J Glass, J McArthur, E Spargo and P Lantos (1994) Neuronal density in the superior frontal and tempral gyri does not correlate with the degree of human immunodeficiency virus-associated dementia. Acta Neuropathol. 88, 538-544.
33. Everall I, F Gray and E Masliah (1997) Neuronal injury and apoptosis, In: Neurological and Neuropsychiatric Manifestations of HIV-1 Infection, Edition 1 (Gendelman H, S Lipton, L Epstein and S Swindells, Eds.) (Chapman and Hall: New York).
34. Everall IP, RK Heaton, TD Marcotte, RJ Ellis, JA McCutchan, JH Atkinson, I Grant, M Mallory, E Masliah and Group THNRC (1999) Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. Brain Pathol. 9, 209-217.
35. Everall IP, G Trillo-Pazos, C Bell, M Mallory, V Sanders and E Masliah (2001) Amelioration of neurotoxic effects of HIV envelope protein gp120 by fibroblast growth factor: A strategy for neuroprotection. J. Neuropathol. Exp. Neurol. 60, 293-301.
36. Fischer-Smith T, S Croul, A Adeniyi, K Rybicka, S Morgello, K Khalili and J Rappaport (2004) Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Am. J. Pathol. 164, 2089-2099.
37. Forton DM, HC Thomas and SD Taylor-Robinson (2004a) Central nervous system involvement in hepatitis C virus infection. Metab. Brain Dis. 19, 383-391.
38. Forton DM, P Karayiannis, N Mahmud, SD Taylor-Robinson and HC Thomas (2004b) Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J. Virol. 78, 5170-5183.
39. Fox L, M Mallory, C Achim and E Masliah (1997) Neurodegeneration od somatostatin-immunoreactive neurons in HIV encephalitis. J. Neuropathol. Exp. Neurol. 56, 360-368.
40. Garden GA, SL Budd, E Tsai, L Hanson, M Kaul, DM D'Emilia, RM Friedlander, J Yuan, E Masliah and SA Lipton (2002) Caspase cascades in human immunodeficiency virus-associated neurodegeneration. J. Neurosci. 22, 4015-4024.
41. Gendelman H and S Lipton, M Tardieu, M Bukrinsky and H Nottet (1994) The neuropathogenesis of HIV-1 infection. J. Leukocyte Biol. 56, 389-398.
42. Gendelman HE, Y Persidsky, A Ghorpade, J Limoges, M Stins, M Fiala and R Morrisett (1997) The neuropathogenesis of the AIDS dementia complex. Aids 11(Suppl. A), S35-S45.
43. Giulian D, K Vaca and C Noonan (1990) Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250, 1593-1596.
44. Glass J, H Fedor, S Wesselingh and J McArthur (1995) Immunocytochemical quantification of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38, 755-762.
45. Gonzalez-Scarano F and J Martin-Garcia (2005) The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5, 69-81.
46. Gonzalez RG, LL Cheng, SV Westmoreland, KE Sakaie, LR Becerra, PL Lee, E Masliah and AA Lackner A (2000) Early brain injury in the SIV-macaque model of AIDS. Aids 14, 2841-2849.
47. Grant I and RK Heaton (1990) Human immunodeficiency virus-type 1 (HIV-1) and the brain. J. Consult. Clin. Psychol. 58, 22-30.
48. Grant I, JH Atkinson, JR Hesselink, CJ Kennedy, DD Richman, SA Spector and JA McCutchan (1988) Human immunodeficiency virus-associated neurobehavioural disorder. J. R. Coll. Physicians (Lond.) 22, 149-157.
49. Gray F, H Haug, L Chimelli, C Geny, A Gaston, F Scaravilli and H Budka (1991) Prominent cortical atrophy with neuronal loss as correlate of human immunodeficiency virus encephalopathy. Acta Neuropathol. (Berl.) 82, 229-233.
50. Gray F, H Adle-Biassette, F Chretien, G Lorin de la Grandmaison, G Force and C Keohane (2001) Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin. Neuropathol. 20, 146-155.
51. Gray F, F Chretien, AV Vallat-Decouvelaere and F Scaravilli (2003) The changing pattern of HIV neuropathology in the HAART era. J. Neuropathol. Exp. Neurol. 62, 429-440.
52. Green DA, E Masliah, HV Vinters, P Beizai, DJ Moore and CL Achim (2005) Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. Aids 19, 407-411.
53. James HJ, LR Sharer, Q Zhang, HG Wang, LG Epstein, JC Reed and HA Gelbard (1999) Expression of caspase-3 in brains from paediatric patients with HIV-1 encephalitis. Neuropathol. Appl. Neurobiol. 25, 380-386.
54. Jellinger KA, U Setinek, M Drlicek, G Bohm, A Steurer and F Lintner (2000) Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta Neuropathol. (Berl.) 100, 213-220.
55. Johnson R, J Glass, J McArthur and B Cheesbro (1996) Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome. Ann. Neurol. 39, 392-395.
56. Kandanearatchi A, M Zuckerman, M Smith, A Vyakarnam and IP Everall (2002) Granulocyte-macrophage colony-stimulating factor enhances viral load in human brain tissue: Amelioration with stavudine. Aids 16, 413-420.
57. Kaul M and SA Lipton (1999) Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 96, 8212-8216.
58. Kaul M, GA Garden and SA Lipton (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410, 988-994.
59. Kramer-Hammerle S, I Rothenaigner, H Wolff, JE Bell and R Brack-Werner (2005) Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res. 111, 194-213.
60. Langford D and E Masliah (2001) Crosstalk between components of the blood brain barrier and cells of the CNS in microglial activation in AIDS. Brain Pathol. 11, 306-312.
61. Langford D, A Adame, A Grigorian, I Grant, JA McCutchan, RJ Ellis, TD Marcotte and E Masliah (2003) Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J. Acquir. Immune Defic. Syndr. 34, 467-474.
62. Langford D, A Grigorian, R Hurford, A Adame, L Crews and E Masliah (2004) The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus tat protein and methamphetamine on calbindin positive-neurons. J. Neurovirol. 10, 327-337.
63. Langford T, SL Letendre, GJ Larrea and E Masliah (2002a) Changing patterns in the neuropathogenesis of HIV during the HAART Era. Brain Pathol. 11, 306-312.
64. Langford TD, SL Letendre, TD Marcotte, RJ Ellis, JA McCutchan, I Grant, ME Mallory, LA Hansen, S Archibald, T Jernigan and E Masliah (2002b) Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 16, 1019-1029.
65. Laskus T, M Radkowski, A Piasek, M Nowicki, A Horban, J Cianciara and J Rakela (2000) Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: Evidence of active replication in monocytes/macrophages and lymphocytes. J. Infect. Dis. 181, 442-448.
66. Laskus T, M Radkowski, J Jablonska, K Kibler, J Wilkinson, D Adair and J Rakela (2004) Human immunodeficiency virus facilitates infection/ replication of hepatitis C virus in native human macrophages. Blood 103, 3854-3859.
67. Lawrence DM and EO Major (2002) HIV-1 and the brain: Connections between HIV-1-associated dementia, neuropathology and neuroimmunology. Microbes Infect. 4, 301-308.
68. Lopez OL, G Smith, CC Meltzer and JT Becker (1999) Dopamine systems in human immunodeficiency virus-associated dementia. Neuropsychiatr. Neuropsychol. Behav. Neurol. 12, 184-192.
69. Lyoo IK, CC Streeter, KH Ahn, HK Lee, MH Pollack, MM Silveri, L Nassar, JM Levin, O Sarid-Segal, DA Ciraulo, PF Renshaw and MJ Kaufman (2004) White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects. Psychiatry Res. 131, 135-145.
70. Mamidi A, JA DeSimone and RJ Pomerantz (2002) Central nervous system infections in individuals with HIV-1 infection. J. Neurovirol. 8, 158-167.
71. Marcus CD, SD Taylor-Robinson, J Sargentoni, JG Ainsworth, G Frize, PJ Easterbrook, S Shaunak and DJ Bryant (1998) 1H MR spectroscopy of the brain in HIV-1-seropositive subjects: Evidence for diffuse metabolic abnormalities. Metab. Brain Dis. 13, 123-136.
72. Martin L, C Blackstone, A Levey, R Huganir and D Price (1993) AMPA glutamate receptor subunits are differentially distributed in rat brain. Neuroscience 53, 327-358.
73. Martin-Garcia J, DL Kolson and F Gonzalez-Scarano (2002) Chemokine receptors in the brain: Their role in HIV infection and pathogenesis. Aids 16, 1709-1730.
74. Maschke M, O Kastrup, S Esser, B Ross, U Hengge and A Hufnagel (2000) Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J. Neurol. Neurosurg. Psychiatry 69, 376-380.
75. Masliah E (1996) In vivo modeling of HIV-1 mediated neurodegeneration. Am. J. Pathol. 149, 745-750.
76. Masliah E (2001) Recent advances in the understanding of the role of synaptic proteins in Alzheimer's disease and other neurode-generative disorders. J. Alz. Dis. 3, 1-9.
77. Masliah E, CL Achim, N Ge, R De Teresa and CA Wiley (1994) Cellular neuropathology in HIV encephalitis. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 72, 119-131.
78. Masliah E, N Ge, C Achim, L Hansen and C Wiley (1992b) Selective neuronal vulnerability in HIV encephalitis. J. Neuropathol. Exp. Neurol. 51, 585-593.
79. Masliah E, C Achim, N Ge, R DeTeresa, R Terry and C Wiley (1992c) Spectrum of human immunodeficiency virus-associated neocortical damage. Ann. Neurol. 32, 321-329.
80. Masliah E, N Ge, C Achim and C Wiley (1994) Cytokine receptor localization in human central nervous system in vivo and in vitro: correlation with HIV infection. Brain Res. 663, 1-6.
81. Masliah E, N Ge, C Achim and C Wiley (1995) Differential vulnerability of calbindin-immunoreactive neurons in HIV encephalitis. J. Neuropathol. Exp. Neurol. 54, 350-357.
82. Masliah E, N Ge and L Mucke (1996a) Pathogenesis of HIV-1 associated neurodegeneration. Crit. Rev. Neurobiol. 10, 57-67.
83. Masliah E, N Ge, C Achim, R DeTeresa and C Wiley (1996b) Patterns of neurodegeneration in HIV encephalitis. NeuroAIDS 1, 161-173.
84. Masliah E, R DeTeresa, M Mallory and L Hansen (2000) Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 14, 69-74.
85. McArthur JC (2004) HIV dementia: An evolving disease. J. Neuroimmunol. 157, 3-10.
86. McArthur JC, DR McClernon, MF Cronin, TE Nance-Sproson, AJ Saah, M St Clair and ER Lanier (1997) Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann. Neurol. 42, 689-698.
87. McArthur JC, N Haughey, S Gartner, K Conant, C Pardo, A Nath and N Sacktor (2003) Human immunodeficiency virus-associated dementia: An evolving disease. J. Neurovirol. 9, 205-221.
88. McClernon DR, R Lanier, S Gartner, P Feaser, CA Pardo, M St Clair, Q Liao and JC McArthur (2001) HIV in the brain: RNA levels and patterns of zidovudine resistance. Neurology 57, 1396-1401.
89. Meucci O, A Fatatis, AA Simen, TJ Bushell, PW Gray and RJ Miller (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA 95, 14500-14505.
90. Minagar A, P Shapshak, R Fujimura, R Ownby, M Heyes and C Eisdorfer (2002) The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J. Neurol. Sci. 202, 13-23.
91. Mirra S and C del Rio (1989) The fine structure of acquired immunodeficiency syndrome encephalopathy. Arch. Pathol. Lab. Med. 113, 858-865.
92. Mukhtar M, S Harley, P Chen, M BouHamdan, C Patel, E Acheampong and RJ Pomerantz (2002) Primary isolated human brain microvascular endothelial cells express diverse HIV/SIV-associated chemokine coreceptors and DC-SIGN and L-SIGN. Virology 297, 78-88.
93. Nath A, C Anderson, M Jones, W Maragos, R Booze, C Mactutus, J Bell, KF Hauser and M Mattson (2000) Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J. Psychopharmacol. 14, 222-227.
94. Neuenburg JK, HR Brodt, BG Herndier, M Bickel, P Bacchetti, RW Price, RM Grant and W Schlote (2002) HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 31, 171-177.
95. Nukuna A, HE Gendelman, J Limoges, J Rasmussen, L Poluektova, A Ghorpade and Y Persidsky (2004) Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis. J. Neurovirol. 10 (Suppl. 1), 82-90.
96. Persidsky Y, A Ghorpade, J Rasmussen, J Limoges, XJ Liu, M Stins, M Fiala, D Way, KS Kim, MH Witte, M Weinand, L Carhart and HE Gendelman (1999) Microglial and astrocyte che-mokines regulate monocyte migration through the blood-brain barrier in HIV-1 encephalitis. Am. J. Pathol. 155, 1599-1611.
97. Price R (1994) Understanding the AIDS dementia complex (ADC) The challenge of HIV and its effects on the central nervous system, In: HIV, AIDS, and the Brain (Price R, S Perry III, Eds.) (Raven Press: New York), pp 1-45.
98. Pulliam L, B Herndier, N Tang and M McGrath (1991) Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J. Clin. Invest. 87, 503-512.
99. Pulliam L, JA Clarke, D McGuire and MS McGrath (1994) Investigation of HIV-infected macrophage neurotoxin production from patients with AIDS dementia. Adv. Neuroimmunol. 4, 195-198.
100. Pulliam L, M Zhou, M Stubblebine and CM Bitler (1998) Differential modulation of cell death proteins in human brain cells by tumor necrosis factor alpha and platelet activating factor. J. Neurosci. Res. 54, 530-538.
101. Radkowski M, J Wilkinson, M Nowicki, D Adair, H Vargas, C Ingui, J Rakela and T Laskus (2002) Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: Evidence of replication. J. Virol. 76, 600-608.
102. Ramirez SH, JF Sanchez, CA Dimitri, HA Gelbard, S Dewhurst and SB Maggirwar (2001) Neurotrophins prevent HIV Tat-induced neuronal apoptosis via a nuclear factor-kappaB (NF-kappaB)-dependent mechanism. J. Neurochem. 78, 874-889.
103. Rempel HC and L Pulliam (2005) HIV-1 Tat inhibits neprilysin and elevates amyloid beta. Aids 19, 127-135.
104. Sacktor N, MP McDermott, K Marder, G Schifitto, OA Selnes, JC McArthur, Y Stern, S Albert, D Palumbo, K Kieburtz, JA De Marcaida, B Cohen and L Epstein (2002) HIV-associated cognitive impairment before and after the advent of combination therapy. J. Neurovirol. 8, 136-142.
105. Sanders VJ, CA Pittman, MG White, G Wang, CA Wiley and CL Achim (1998) Chemokines and receptors in HIV encephalitis. Aids 12, 1021-1026.
106. Sanders V, IP Everall, RW Johnson and E Masliah and the HNRC group (2000) Fibroblast growth factor modulates HIV co-receptor expression by neural cells. J. Neurosci. Res. 59, 671-679.
107. Smith TW, U DeGirolami, D Henin, F Bolgert and JJ Hauw (1990) Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J. Neuropathol. Exp. Neurol. 49, 357-370.
108. Speth C, MP Dierich and S Sopper (2005) HIV-infection of the central nervous system: The tightrope walk of innate immunity. Mol. Immunol. 42, 213-228.
109. Takahashi K, SL Wesselingh, DE Griffin, JC McArthur, RT Johnson and JD Glass (1996) Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocyto-chemistry. Ann. Neurol. 39, 705-711.
110. Thompson PM, KM Hayashi, SL Simon, JA Geaga, MS Hong, Y Sui, JY Lee, AW Toga, W Ling and ED London (2004) Structural abnormalities in the brains of human subjects who use metham-phetamine. J. Neurosci. 24, 6028-6036.
111. Torres-Munoz J, P Stockton, N Tacoronte, B Roberts, RR Maronpot and CK Petito (2001) Detection of HIV-1 gene sequences in hippocampal neurons isolated from postmortem AIDS brains by laser capture microdissection. J. Neuropathol. Exp. Neurol. 60, 885-892.
112. Trillo-Pazos G, A Diamanturos, L Rislove, T Menza, W Chao, P Belem, S Sadiq, S Morgello, L Sharer and DJ Volsky (2003) Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol. 13, 144-154.
113. Vargas HE, T Laskus, M Radkowski, J Wilkinson, V Balan, DD Douglas, ME Harrison, DC Mulligan, K Olden, D Adair and J Rakela (2002) Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation. Liver Transpl. 8, 1014-1019.
114. Wang Z, G Trillo-Pazos, SY Kim, M Canki, S Morgello, LR Sharer, HA Gelbard, ZZ Su, DC Kang, AI Brooks, PB Fisher and DJ Volsky (2004) Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: Potential role in neu-ropathogenesis. J. Neurovirol. 10 (Suppl. 1), 25-32.
115. Weis S, H Haug and H Budka (1993) Neuronal damage in the cerebral cortex of AIDS brains: A morphometric study. Acta Neuropathol. 85, 185-189.
116. Wiley CA (2003) Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol. 13, 415; author reply 415-416.
117. Wiley C and C Achim (1994) HIV encephalitis is the pathologic correlate of dementia in AIDS. Ann. Neurol. 36, 673-676.
118. Wiley CA, RD Schrier, JA Nelson, PW Lampert and MB Oldstone (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83, 7089-7093.
119. Wiley C, N Ge, M Morey, R DeTeresa, R Terry and E Masliah (1991a) Golgi impregnation studies of dendritic pathology in HIV encepahlitis. J. Neuropathol. Exp. Neurol. 50, 324.
120. Wiley C, E Masliah, M Morey, C Lemere, R DeTeresa, M Grafe, L Hansen and R Terry (1991b) Neocortical damage during HIV infection. Ann. Neurol. 29, 651-657.
121. Wiley CA, V Soontornniyomkij, L Radhakrishnan, E Masliah, J Mellors, SA Hermann, P Dailey and CL Achim (1998) Distribution of brain HIV load in AIDS. Brain Pathol. 8, 277-284.
122. Wiley CA, CL Achim, R Hammond, S Love, E Masliah, L Radhakrishnan, V Sanders and G Wang (2000) Damage and repair of DNA in HIV encephalitis. J. Neuropathol. Exp. Neurol. 59, 955-965.
123. Wilkinson ID, S Lunn, KA Miszkiel, RF Miller, MN Paley, I Williams, RJ Chinn, MA Hall-Craggs, SP Newman, BE Kendall and MJ Harrison (1997) Proton MRS and quantitative MRI assessment of the short term neurological response to antiret-roviral therapy in AIDS. J. Neurol. Neurosurg. Psychiatry 63, 477-482.
124. Wu DT, SE Woodman, JM Weiss, CM McManus, TG D'Aversa, J Hesselgesser, EO Major, A Nath and JW Berman (2000) Mechanisms of leukocyte trafficking into the CNS. J. Neurovirol. 6 (Suppl. 1), S82-S85.
125. Zauli G, P Secchiero, L Rodella, D Gibellini, P Mirandola, M Mazzoni, D Milani, DR Dowd, S Capitani and M Vitale (2000) HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells. J. Biol. Chem. 275, 4159-4165.